Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Amazon Great Indian Festival Celebration Sale - 2019
Google
Web www.equitybulls.com
Stock Report

| More

Biocon Licenses Three Generic Formulation Products to China Medical System Holdings

Posted On: 2019-09-13 11:58:36

Biocon Ltd (BSE code: 532523, NSE: BIOCON), Asia's premier biopharmaceuticals company, today announced that it has signed a License and Supply Agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) for three Generic Formulation products in Greater China.

This development is in line with Biocon's long term generic formulations strategy and expands our Generic Formulations business footprint to the Chinese pharmaceuticals market, which is the second largest pharmaceutical market in the world.

Under the terms of the agreement, Biocon will be responsible for the development, manufacturing and supply of the products. CMS will be responsible for registration and commercialization of the products in China.

The total addressable market size for these three products in Mainland China is about US$ 0.8 billion, as per recent IQVIA data. The initial term of the agreement shall be for 10 years from the date of commercialization, extendable by two years on a product basis by mutual consent. This collaboration can be extended to a broader portfolio in future.

Dr Arun Chandavarkar, CEO and Joint Managing Director, Biocon, said: "We are excited to partner with CMS, which is a leading Chinese pharma company in the Greater China region. This collaboration will allow us to take our US approved Generic Formulations to patients in China, allowing us an early entry in the world's second largest, and rapidly-growing generics market."

China's National Medical Products Administration (NMPA) has recently introduced the Quality Consistency Evaluation (QCE) system, which aims to ensure that all generic medicines marketed or manufactured in China meet internationally recognized quality standards.

The QCE regulations are part of a wide-ranging package of healthcare system reforms introduced by the Chinese government over the past few years to accelerate generic penetration.

Biocon's Generic Formulations business is built on the back of Company's strong portfolio of complex and differentiated APIs. Through forward integration into dosage forms, the Company seeks to provide a safe, efficacious and continuous supply of high quality affordable drugs to address patient needs in diverse markets. We have commenced multiple programs to build a robust pipeline of technology-intensive molecules for global markets. Biocon has successfully commercialized a few products under its own label in the US.

Shares of BIOCON LTD. was last trading in BSE at Rs.232.3 as compared to the previous close of Rs. 234.8. The total number of shares traded during the day was 146340 in over 3404 trades.

The stock hit an intraday high of Rs. 237.95 and intraday low of 230.3. The net turnover during the day was Rs. 34340325.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Indiabulls Housing Finance Limited repays Rs. 1330 crores raised through masala bonds

YES BANK recovers INR 645 crore

Vikas WSP Ltd receives LoC for $30 mn

CRISIL upgrades ratings of Varun Beverages Ltd

HUL Announces Key Appointments to Management Committee

GTPL Hathway appoints Mr. Anil Bothra as its Chief Financial Officer

Brickwork reaffirms ratings of Transcorp International Ltd

TCS Named India's Overall Most Outstanding Company in Asiamoney's 2019 Poll

Tejas Networks launches World's Largest Disaggregated Packet-Optical Switch at India Mobile Congress 2019

Cummins India powering a cleaner and more prosperous India with their BS-VI Certified engines

Early Diwali for investors: IRCTC stock doubles on listing day

Hindustan Unilever Ltd board declares interim dividend of Rs. 11 for 2019-20

Thomas Cook India introduces a unique 'Double Protection Program' comprising Trip Protection + Guaranteed Departures aimed at protecting traveller interests

GTPL Hathway's Consolidated H1 FY20 PAT at Rs. 580 million, up by 102%

YES Bank has sold shares of Fortis Healthcare Ltd

Indiabulls Housing Finance Limited's long-term rating reaffirmed by the rating agency ICRA

Sonata Software Ltd Board to consider Interim Dividend on Oct 30, 2019

Shemaroo Entertainment Ltd board to consider fund raising on Oct 17, 2019

Canara Bank anounces change in Savings Bank Interest Rate w.e.f 15.10.2019

JSW Energy Limited's resolution plan for Ind-Barath Energy (Utkal) Limited approved by the Committee of Creditors

HDFC reduces its RPLR by 10 basis points from Oct 15, 2019

Technocraft Industries India Ltd starts production of melange yarn at Murbad

Taraashna Financial Services Ltd appoints Mr. Partha Sengupta as CEO

RBI slaps Rs. 1 crore fine on Lakshmi Vilas Bank for not adhering to guidelines

Hindustan Unilever Ltd announces Q2 FY19-20 results

Seya Industries maiden foray into China for supply of specialty chemical intermediate

Maruti Suzuki collaborates with five startups under its MAIL program

Granules India Limited to divest its stake in its Joint Venture located in China

Total announces open offer for shares of Adani Gas Ltd at Rs. 149.63

Rajesh Exports Ltd expands its retail arm by opening one more Retail showroom at Chandapura, Bengaluru

Stellar listing by IRCTC

Sun Pharma Launches CEQUA for the Treatment of Dry Eye Disease in the U.S.

Birlasoft to accelerate Invacare's Business Transformation Journey

Morepen Labs adds three new drugs - Rivaroxaban, Vildagliptin and UDCA to its API portfolio

TOTAL joins Adani to create India's premier integrated gas utility

HFCL launches new line of products under brand name 'IO'

IndiGo connects the political capitals of India and Kingdom of Saudi Arabia

Shalby Ltd conferred with 'DARE to DREAM - ZEE BUSINESS AWARD - COMPANY OF THE YEAR'

Avenue Supermarts Ltd consolidated Q2 net profit at Rs. 322.66 crores

Hero MotoCorp to skip upcoming Auto Expo

Chartered Logistics Limited bags award from ZEE Business

Lawreshwar Polymers Ltd is now Lehar Footwears Ltd

CRISIL updates on credit rating of Avenue Supermarts Ltd

Wendt India Ltd board to announce Q2, H1 results on Oct 22, 2019

CARE reaffirms rating of IDFC First Bank Ltd

Reliance Capital Ltd has sold Reliance Financial Limited for Rs. 102 crore

CARE reaffirms CARE A1+ rating for Future Retail's Commercial Paper

CARE reviews ratings of Lakshmi Vilas Bank Ltd

CARE A1+ rating reaffirmed to Future Enterprises Ltd's Commercial Paper

Reliance Capital Ltd has sold Reliance Securities Limited for Rs. 62 crore







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019